Structure Therapeutics Ownership | Who Owns Structure Therapeutics?
Structure Therapeutics Ownership Summary
Structure Therapeutics is owned by 2.98% institutional investors, 2.74% insiders, and 94.28% retail investors. Deep track capital, lp is the largest institutional shareholder, holding 0.72% of GPCR shares.
GPCR Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Structure Therapeutics | 2.98% | 2.74% | 94.28% |
Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Deep track capital, lp | 4.10M | 0.72% | $70.97M |
Vestal point capital, lp | 1.79M | 0.31% | $30.97M |
Bvf inc/il | 1.77M | 0.31% | $30.66M |
Ra capital management | 1.52M | 0.26% | $26.27M |
Driehaus capital management | 1.27M | 0.22% | $22.03M |
Tcg crossover management | 1.06M | 0.19% | $18.40M |
Millennium management | 790.16K | 0.14% | $13.68M |
Casdin capital | 700.00K | 0.12% | $12.12M |
Orbimed advisors | 652.03K | 0.11% | $11.29M |
Foresite capital management vi | 420.00K | 0.07% | $7.27M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Foresite capital management vi | 420.00K | 3.98% | $7.27M |
Tcg crossover management | 1.06M | 2.51% | $18.40M |
Deep track capital, lp | 4.10M | 2.30% | $70.97M |
Vestal point capital, lp | 1.79M | 2.21% | $30.97M |
Exome asset management | 102.94K | 1.58% | $1.78M |
Bvf inc/il | 1.77M | 1.25% | $30.66M |
Casdin capital | 700.00K | 0.99% | $12.12M |
Silverarc capital management | 188.07K | 0.67% | $3.26M |
Monashee investment management | 292.86K | 0.60% | $5.07M |
Ikarian capital | 264.08K | 0.56% | $4.57M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Deep track capital, lp | 4.10M | 2.30% | 1.30M |
Monashee investment management | 292.86K | 0.60% | 160.86K |
Vestal point capital, lp | 1.79M | 2.21% | 63.99K |
Cubist systematic strategies | 54.82K | 0.01% | 54.82K |
Pfm health sciences, lp | 40.40K | 0.05% | 40.40K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Driehaus capital management | 1.27M | 0.21% | -784.67K |
Ensign peak advisors | - | - | -308.24K |
First light asset management | 132.38K | 0.26% | -266.48K |
Superstring capital management lp | - | - | -216.81K |
Alliancebernstein | - | - | -142.82K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Cubist systematic strategies | 54.82K | 0.01% | 54.82K | $948.87K |
Pfm health sciences, lp | 40.40K | 0.05% | 40.40K | $699.32K |
Sold Out
Holder | Change |
---|---|
Fairfield financial advisors | -59.00 |
Clear street markets | -246.00 |
Jefferies financial group | -2.00K |
Virtus etf advisers | -2.24K |
Vestcor | -4.70K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 32 | -82.32% | 17,076,259 | -71.82% | 2 | 0.20% | 11 | -88.17% | 8 | -82.98% |
Dec 31, 2024 | 184 | 4.55% | 60,629,867 | -1.30% | 38 | 2.54% | 94 | -2.08% | 49 | 28.95% |
Sep 30, 2024 | 176 | -9.28% | 61,427,326 | 3.62% | 38 | 21.50% | 96 | -22.58% | 38 | -2.56% |
Jun 30, 2024 | 194 | 34.72% | 59,282,748 | 35.85% | 13 | 13.72% | 124 | 61.04% | 39 | 8.33% |
Mar 31, 2024 | 144 | 4.35% | 43,639,591 | 2.47% | 9 | 10.61% | 77 | -16.30% | 36 | 44.00% |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 06, 2025 | FMR LLC | See Remark 1 | Sell | - |
Jun 10, 2024 | Stevens Raymond C | CHIEF EXECUTIVE OFFICER | Sell | - |
Jun 03, 2024 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell | - |
Jun 03, 2024 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell | - |
Mar 14, 2024 | FMR LLC | See Remark 1 | Sell | - |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | - |
2024 Q2 | - | 3 |
2024 Q1 | - | 2 |
2023 Q4 | - | 4 |
2023 Q3 | - | - |
GPCR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools